Testing effectiveness (Phase 2)Study completedNCT01378975What this trial is testingVemurafenib in Metastatic Melanoma Participants With Brain MetastasesWho this might be right forMalignant Melanoma Hoffmann-La Roche 146
Early research (Phase 1)Study completedNCT02858869What this trial is testingPembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more Emory University 25
Testing effectiveness (Phase 2)Study completedNCT00002973What this trial is testingMelphalan and Whole-Body Hyperthermia in Treating Patients With Advanced MelanomaWho this might be right forMelanoma (Skin) University of Wisconsin, Madison 34
Testing effectiveness (Phase 2)Ended earlyNCT00358319What this trial is testingPhase I/II Trial of Valproic Acid and Karenitecin for MelanomaWho this might be right forMalignant Melanoma H. Lee Moffitt Cancer Center and Research Institute 42
Testing effectiveness (Phase 2)UnknownNCT04884997What this trial is testingToripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant MelanomaWho this might be right forMalignant Melanoma First Affiliated Hospital of Zhejiang University 90
Testing effectiveness (Phase 2)WithdrawnNCT01355562What this trial is testingTrial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney CancerWho this might be right forMelanomaMetastatic Kidney Cancer Loma Linda University
Testing effectiveness (Phase 2)Study completedNCT00066196What this trial is testingEvaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic MelanomaWho this might be right forMelanomaMalignant Metastatic Melanoma MedImmune LLC 110
Testing effectiveness (Phase 2)Study completedNCT00256282What this trial is testingDocetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant MelanomaWho this might be right forMetastatic Melanoma John P. Fruehauf 52
Very early researchEnded earlyNCT02591654What this trial is testingMRI and PET to Assess Pembrolizumab ResponseWho this might be right forMalignant Melanoma, Metastatic Columbia University 6
Large-scale testing (Phase 3)Study completedNCT00039000What this trial is testingStudy of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV MelanomaWho this might be right forMalignant Melanoma Agenus Inc. 350
Testing effectiveness (Phase 2)Ended earlyNCT00961844What this trial is testingTrial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant MelanomaWho this might be right forMetastatic Malignant Melanoma Steinar Aamdal 15
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT01898585What this trial is testingAn Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 60
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00238329What this trial is testingPEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Barbara Ann Karmanos Cancer Institute 32
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Early research (Phase 1)Study completedNCT01656642What this trial is testingA Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaWho this might be right forMalignant Melanoma Genentech, Inc. 67
Early research (Phase 1)Ended earlyNCT01519323What this trial is testingBRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 MutationsWho this might be right forMalignant Melanoma Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Study completedNCT02304458What this trial is testingNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasWho this might be right forMetastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)UnknownNCT01168050What this trial is testingEfficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.Who this might be right forMalignant Skin Melanoma T0Stage III MelanomaStage IV Melanoma+1 more Assistance Publique - Hôpitaux de Paris 25